Synergy was observed in multiple tumor types (Fig. 2a, Supplemental Table S3), with the combination improving growth inhibition (gIC50, gIC100) and/or cytotoxicity (dEC50) even in cell lines sensitive to single agent BET inhibition (Fig. 2b, c, Supplemental Table S1, S3). Here, DNER is linked to neoplasm.